nodes	percent_of_prediction	percent_of_DWPC	metapath
Ivermectin—ABCC1—Vandetanib—thyroid cancer	0.185	0.217	CbGbCtD
Ivermectin—ABCC1—Epirubicin—thyroid cancer	0.127	0.149	CbGbCtD
Ivermectin—ABCG2—Vandetanib—thyroid cancer	0.124	0.145	CbGbCtD
Ivermectin—ABCC2—Sorafenib—thyroid cancer	0.0824	0.0969	CbGbCtD
Ivermectin—ABCG2—Sorafenib—thyroid cancer	0.0745	0.0876	CbGbCtD
Ivermectin—ABCC1—Doxorubicin—thyroid cancer	0.0676	0.0794	CbGbCtD
Ivermectin—ABCC2—Doxorubicin—thyroid cancer	0.05	0.0588	CbGbCtD
Ivermectin—ABCG2—Doxorubicin—thyroid cancer	0.0452	0.0531	CbGbCtD
Ivermectin—ABCB1—Sorafenib—thyroid cancer	0.0269	0.0316	CbGbCtD
Ivermectin—CYP3A4—Vandetanib—thyroid cancer	0.0267	0.0314	CbGbCtD
Ivermectin—ABCB1—Doxorubicin—thyroid cancer	0.0163	0.0192	CbGbCtD
Ivermectin—CYP3A4—Sorafenib—thyroid cancer	0.0161	0.0189	CbGbCtD
Ivermectin—CYP3A4—Doxorubicin—thyroid cancer	0.00977	0.0115	CbGbCtD
Ivermectin—Faecal incontinence—Vandetanib—thyroid cancer	0.0046	0.0537	CcSEcCtD
Ivermectin—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.00447	0.0708	CbGpPWpGaD
Ivermectin—NR1H4—Synthesis of bile acids and bile salts via 27-hydroxycholesterol—RXRA—thyroid cancer	0.00295	0.0467	CbGpPWpGaD
Ivermectin—NR1H4—Recycling of bile acids and salts—RXRA—thyroid cancer	0.0028	0.0444	CbGpPWpGaD
Ivermectin—NR1H4—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00261	0.0413	CbGpPWpGaD
Ivermectin—NR1H4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.00244	0.0387	CbGpPWpGaD
Ivermectin—Depressed level of consciousness—Vandetanib—thyroid cancer	0.00224	0.0262	CcSEcCtD
Ivermectin—Oropharyngeal discomfort—Sorafenib—thyroid cancer	0.00216	0.0252	CcSEcCtD
Ivermectin—NR1H4—Endogenous sterols—RXRA—thyroid cancer	0.0021	0.0332	CbGpPWpGaD
Ivermectin—NR1H4—Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol—RXRA—thyroid cancer	0.00203	0.0321	CbGpPWpGaD
Ivermectin—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—RXRA—thyroid cancer	0.0019	0.0301	CbGpPWpGaD
Ivermectin—NR1H4—Synthesis of bile acids and bile salts—RXRA—thyroid cancer	0.00184	0.0292	CbGpPWpGaD
Ivermectin—Lethargy—Vandetanib—thyroid cancer	0.00172	0.0201	CcSEcCtD
Ivermectin—Sensitisation—Epirubicin—thyroid cancer	0.00162	0.0189	CcSEcCtD
Ivermectin—Dry skin—Vandetanib—thyroid cancer	0.00155	0.018	CcSEcCtD
Ivermectin—ABCC1—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00152	0.0241	CbGpPWpGaD
Ivermectin—Sensitisation—Doxorubicin—thyroid cancer	0.0015	0.0175	CcSEcCtD
Ivermectin—NR1H4—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.00146	0.0232	CbGpPWpGaD
Ivermectin—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00129	0.015	CcSEcCtD
Ivermectin—Conjunctivitis—Vandetanib—thyroid cancer	0.00126	0.0147	CcSEcCtD
Ivermectin—Haematuria—Vandetanib—thyroid cancer	0.00124	0.0145	CcSEcCtD
Ivermectin—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—PPARG—thyroid cancer	0.0012	0.019	CbGpPWpGaD
Ivermectin—NR1H4—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00111	0.0176	CbGpPWpGaD
Ivermectin—Erythema multiforme—Vandetanib—thyroid cancer	0.0011	0.0129	CcSEcCtD
Ivermectin—Blindness—Epirubicin—thyroid cancer	0.00105	0.0122	CcSEcCtD
Ivermectin—Dry skin—Sorafenib—thyroid cancer	0.00104	0.0122	CcSEcCtD
Ivermectin—Abdominal pain upper—Sorafenib—thyroid cancer	0.00104	0.0121	CcSEcCtD
Ivermectin—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00102	0.012	CcSEcCtD
Ivermectin—NR1H4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000973	0.0154	CbGpPWpGaD
Ivermectin—Blindness—Doxorubicin—thyroid cancer	0.000968	0.0113	CcSEcCtD
Ivermectin—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000968	0.0153	CbGpPWpGaD
Ivermectin—Tremor—Vandetanib—thyroid cancer	0.000952	0.0111	CcSEcCtD
Ivermectin—Abdominal discomfort—Sorafenib—thyroid cancer	0.000943	0.011	CcSEcCtD
Ivermectin—Keratitis—Epirubicin—thyroid cancer	0.000893	0.0104	CcSEcCtD
Ivermectin—Cough—Vandetanib—thyroid cancer	0.000886	0.0103	CcSEcCtD
Ivermectin—Convulsion—Vandetanib—thyroid cancer	0.00088	0.0103	CcSEcCtD
Ivermectin—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.000869	0.0101	CcSEcCtD
Ivermectin—ABCG2—Iron uptake and transport—CP—thyroid cancer	0.000868	0.0137	CbGpPWpGaD
Ivermectin—Chest pain—Vandetanib—thyroid cancer	0.000865	0.0101	CcSEcCtD
Ivermectin—Arthralgia—Vandetanib—thyroid cancer	0.000865	0.0101	CcSEcCtD
Ivermectin—Seborrhoeic dermatitis—Epirubicin—thyroid cancer	0.00085	0.00992	CcSEcCtD
Ivermectin—Oedema—Vandetanib—thyroid cancer	0.000829	0.00968	CcSEcCtD
Ivermectin—Keratitis—Doxorubicin—thyroid cancer	0.000826	0.00965	CcSEcCtD
Ivermectin—ABCG2—HIF-2-alpha transcription factor network—EPO—thyroid cancer	0.000822	0.013	CbGpPWpGaD
Ivermectin—ABCC2—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000795	0.0126	CbGpPWpGaD
Ivermectin—NR1H4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000789	0.0125	CbGpPWpGaD
Ivermectin—Seborrhoeic dermatitis—Doxorubicin—thyroid cancer	0.000786	0.00918	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000755	0.00882	CcSEcCtD
Ivermectin—ABCG2—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.000751	0.0119	CbGpPWpGaD
Ivermectin—Erythema multiforme—Sorafenib—thyroid cancer	0.000744	0.00869	CcSEcCtD
Ivermectin—Dyspnoea—Vandetanib—thyroid cancer	0.000739	0.00863	CcSEcCtD
Ivermectin—Decreased appetite—Vandetanib—thyroid cancer	0.000721	0.00841	CcSEcCtD
Ivermectin—Fatigue—Vandetanib—thyroid cancer	0.000715	0.00834	CcSEcCtD
Ivermectin—Constipation—Vandetanib—thyroid cancer	0.000709	0.00828	CcSEcCtD
Ivermectin—Pain—Vandetanib—thyroid cancer	0.000709	0.00828	CcSEcCtD
Ivermectin—NR1H4—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.0007	0.0111	CbGpPWpGaD
Ivermectin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000678	0.00791	CcSEcCtD
Ivermectin—Body temperature increased—Vandetanib—thyroid cancer	0.000655	0.00765	CcSEcCtD
Ivermectin—Abdominal pain—Vandetanib—thyroid cancer	0.000655	0.00765	CcSEcCtD
Ivermectin—Anaemia—Sorafenib—thyroid cancer	0.000633	0.00739	CcSEcCtD
Ivermectin—NR1H4—Orphan transporters—RXRA—thyroid cancer	0.000627	0.00993	CbGpPWpGaD
Ivermectin—NR1H4—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000623	0.00987	CbGpPWpGaD
Ivermectin—GLRA3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000617	0.00976	CbGpPWpGaD
Ivermectin—GLRA3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000617	0.00976	CbGpPWpGaD
Ivermectin—ABCG2—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000616	0.00976	CbGpPWpGaD
Ivermectin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000614	0.00972	CbGpPWpGaD
Ivermectin—Leukopenia—Sorafenib—thyroid cancer	0.000613	0.00716	CcSEcCtD
Ivermectin—GLRA3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000607	0.00961	CbGpPWpGaD
Ivermectin—NR1H4—PPARA activates gene expression—RXRA—thyroid cancer	0.000599	0.00949	CbGpPWpGaD
Ivermectin—Cough—Sorafenib—thyroid cancer	0.000598	0.00698	CcSEcCtD
Ivermectin—Asthenia—Vandetanib—thyroid cancer	0.000595	0.00694	CcSEcCtD
Ivermectin—ABCC1—S1P1 pathway—PTGS2—thyroid cancer	0.000592	0.00938	CbGpPWpGaD
Ivermectin—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—thyroid cancer	0.000587	0.00929	CbGpPWpGaD
Ivermectin—Pruritus—Vandetanib—thyroid cancer	0.000587	0.00685	CcSEcCtD
Ivermectin—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000584	0.00925	CbGpPWpGaD
Ivermectin—Arthralgia—Sorafenib—thyroid cancer	0.000583	0.00681	CcSEcCtD
Ivermectin—Myalgia—Sorafenib—thyroid cancer	0.000583	0.00681	CcSEcCtD
Ivermectin—Diarrhoea—Vandetanib—thyroid cancer	0.000567	0.00662	CcSEcCtD
Ivermectin—Dizziness—Vandetanib—thyroid cancer	0.000548	0.0064	CcSEcCtD
Ivermectin—Anorexia—Sorafenib—thyroid cancer	0.000533	0.00622	CcSEcCtD
Ivermectin—Coma—Epirubicin—thyroid cancer	0.000529	0.00618	CcSEcCtD
Ivermectin—Vomiting—Vandetanib—thyroid cancer	0.000527	0.00615	CcSEcCtD
Ivermectin—Rash—Vandetanib—thyroid cancer	0.000523	0.0061	CcSEcCtD
Ivermectin—Dermatitis—Vandetanib—thyroid cancer	0.000522	0.0061	CcSEcCtD
Ivermectin—Headache—Vandetanib—thyroid cancer	0.000519	0.00606	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00051	0.00595	CcSEcCtD
Ivermectin—Dyspnoea—Sorafenib—thyroid cancer	0.000499	0.00582	CcSEcCtD
Ivermectin—Lymphadenopathy—Epirubicin—thyroid cancer	0.000493	0.00575	CcSEcCtD
Ivermectin—Nausea—Vandetanib—thyroid cancer	0.000492	0.00575	CcSEcCtD
Ivermectin—Coma—Doxorubicin—thyroid cancer	0.00049	0.00572	CcSEcCtD
Ivermectin—Decreased appetite—Sorafenib—thyroid cancer	0.000486	0.00567	CcSEcCtD
Ivermectin—ABCG2—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000484	0.00766	CbGpPWpGaD
Ivermectin—Fatigue—Sorafenib—thyroid cancer	0.000482	0.00563	CcSEcCtD
Ivermectin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000478	0.00757	CbGpPWpGaD
Ivermectin—Pain—Sorafenib—thyroid cancer	0.000478	0.00558	CcSEcCtD
Ivermectin—Constipation—Sorafenib—thyroid cancer	0.000478	0.00558	CcSEcCtD
Ivermectin—GLRA3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000462	0.00731	CbGpPWpGaD
Ivermectin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000457	0.00534	CcSEcCtD
Ivermectin—Lymphadenopathy—Doxorubicin—thyroid cancer	0.000456	0.00532	CcSEcCtD
Ivermectin—NR1H4—Generic Transcription Pathway—THRB—thyroid cancer	0.000451	0.00714	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000446	0.00706	CbGpPWpGaD
Ivermectin—Urticaria—Sorafenib—thyroid cancer	0.000444	0.00519	CcSEcCtD
Ivermectin—Body temperature increased—Sorafenib—thyroid cancer	0.000442	0.00516	CcSEcCtD
Ivermectin—Abdominal pain—Sorafenib—thyroid cancer	0.000442	0.00516	CcSEcCtD
Ivermectin—Lethargy—Epirubicin—thyroid cancer	0.000429	0.00501	CcSEcCtD
Ivermectin—NR1H4—Biological oxidations—RXRA—thyroid cancer	0.000419	0.00664	CbGpPWpGaD
Ivermectin—Hypersensitivity—Sorafenib—thyroid cancer	0.000412	0.00481	CcSEcCtD
Ivermectin—Face oedema—Epirubicin—thyroid cancer	0.000406	0.00474	CcSEcCtD
Ivermectin—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000404	0.0064	CbGpPWpGaD
Ivermectin—Asthenia—Sorafenib—thyroid cancer	0.000401	0.00468	CcSEcCtD
Ivermectin—Lethargy—Doxorubicin—thyroid cancer	0.000397	0.00463	CcSEcCtD
Ivermectin—Pruritus—Sorafenib—thyroid cancer	0.000396	0.00462	CcSEcCtD
Ivermectin—GLRA3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000388	0.00614	CbGpPWpGaD
Ivermectin—Dry skin—Epirubicin—thyroid cancer	0.000385	0.0045	CcSEcCtD
Ivermectin—Abdominal pain upper—Epirubicin—thyroid cancer	0.000384	0.00448	CcSEcCtD
Ivermectin—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000384	0.00448	CcSEcCtD
Ivermectin—Diarrhoea—Sorafenib—thyroid cancer	0.000383	0.00447	CcSEcCtD
Ivermectin—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000379	0.00442	CcSEcCtD
Ivermectin—NR1H4—PPARA activates gene expression—PPARG—thyroid cancer	0.000378	0.00599	CbGpPWpGaD
Ivermectin—Face oedema—Doxorubicin—thyroid cancer	0.000376	0.00438	CcSEcCtD
Ivermectin—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000374	0.00592	CbGpPWpGaD
Ivermectin—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	0.00037	0.00586	CbGpPWpGaD
Ivermectin—Dizziness—Sorafenib—thyroid cancer	0.00037	0.00432	CcSEcCtD
Ivermectin—Abdominal distension—Epirubicin—thyroid cancer	0.000366	0.00427	CcSEcCtD
Ivermectin—Asthma—Epirubicin—thyroid cancer	0.000363	0.00424	CcSEcCtD
Ivermectin—Eosinophilia—Epirubicin—thyroid cancer	0.00036	0.0042	CcSEcCtD
Ivermectin—Dry skin—Doxorubicin—thyroid cancer	0.000357	0.00416	CcSEcCtD
Ivermectin—Vomiting—Sorafenib—thyroid cancer	0.000356	0.00415	CcSEcCtD
Ivermectin—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000355	0.00415	CcSEcCtD
Ivermectin—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000355	0.00415	CcSEcCtD
Ivermectin—Rash—Sorafenib—thyroid cancer	0.000353	0.00412	CcSEcCtD
Ivermectin—Dermatitis—Sorafenib—thyroid cancer	0.000352	0.00411	CcSEcCtD
Ivermectin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00035	0.00409	CcSEcCtD
Ivermectin—Headache—Sorafenib—thyroid cancer	0.00035	0.00409	CcSEcCtD
Ivermectin—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.00035	0.00554	CbGpPWpGaD
Ivermectin—Abdominal distension—Doxorubicin—thyroid cancer	0.000339	0.00395	CcSEcCtD
Ivermectin—GABRB3—Orphan transporters—RXRA—thyroid cancer	0.000338	0.00536	CbGpPWpGaD
Ivermectin—Asthma—Doxorubicin—thyroid cancer	0.000336	0.00393	CcSEcCtD
Ivermectin—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000333	0.00528	CbGpPWpGaD
Ivermectin—Eosinophilia—Doxorubicin—thyroid cancer	0.000333	0.00389	CcSEcCtD
Ivermectin—Nausea—Sorafenib—thyroid cancer	0.000332	0.00388	CcSEcCtD
Ivermectin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000332	0.00525	CbGpPWpGaD
Ivermectin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000321	0.00375	CcSEcCtD
Ivermectin—Conjunctivitis—Epirubicin—thyroid cancer	0.000315	0.00368	CcSEcCtD
Ivermectin—Haematuria—Epirubicin—thyroid cancer	0.000309	0.00361	CcSEcCtD
Ivermectin—NR1H4—Metabolism—MINPP1—thyroid cancer	0.000308	0.00488	CbGpPWpGaD
Ivermectin—ABCG2—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000301	0.00477	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—TRIM33—thyroid cancer	0.0003	0.00475	CbGpPWpGaD
Ivermectin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000297	0.00347	CcSEcCtD
Ivermectin—Conjunctivitis—Doxorubicin—thyroid cancer	0.000291	0.0034	CcSEcCtD
Ivermectin—Hepatitis—Epirubicin—thyroid cancer	0.000291	0.0034	CcSEcCtD
Ivermectin—ABCG2—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000288	0.00456	CbGpPWpGaD
Ivermectin—Oedema peripheral—Epirubicin—thyroid cancer	0.000287	0.00335	CcSEcCtD
Ivermectin—NR1H4—Generic Transcription Pathway—MEN1—thyroid cancer	0.000286	0.00453	CbGpPWpGaD
Ivermectin—Haematuria—Doxorubicin—thyroid cancer	0.000286	0.00334	CcSEcCtD
Ivermectin—ABCC2—NRF2 pathway—SLC5A5—thyroid cancer	0.000281	0.00445	CbGpPWpGaD
Ivermectin—Erythema multiforme—Epirubicin—thyroid cancer	0.000275	0.00321	CcSEcCtD
Ivermectin—ABCC1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000273	0.00433	CbGpPWpGaD
Ivermectin—Hepatitis—Doxorubicin—thyroid cancer	0.000269	0.00314	CcSEcCtD
Ivermectin—Oedema peripheral—Doxorubicin—thyroid cancer	0.000265	0.0031	CcSEcCtD
Ivermectin—NR1H4—Metabolism—NDUFA13—thyroid cancer	0.000262	0.00415	CbGpPWpGaD
Ivermectin—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000261	0.00414	CbGpPWpGaD
Ivermectin—Chills—Epirubicin—thyroid cancer	0.000261	0.00305	CcSEcCtD
Ivermectin—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	0.000255	0.00404	CbGpPWpGaD
Ivermectin—Erythema multiforme—Doxorubicin—thyroid cancer	0.000254	0.00297	CcSEcCtD
Ivermectin—NR1H4—Metabolism—CHST14—thyroid cancer	0.000246	0.0039	CbGpPWpGaD
Ivermectin—Back pain—Epirubicin—thyroid cancer	0.000245	0.00286	CcSEcCtD
Ivermectin—NR1H4—Transmembrane transport of small molecules—CP—thyroid cancer	0.000243	0.00385	CbGpPWpGaD
Ivermectin—NR1H4—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000243	0.00385	CbGpPWpGaD
Ivermectin—Chills—Doxorubicin—thyroid cancer	0.000242	0.00282	CcSEcCtD
Ivermectin—NR1H4—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000239	0.00379	CbGpPWpGaD
Ivermectin—ABCC2—NRF2 pathway—RXRA—thyroid cancer	0.000236	0.00374	CbGpPWpGaD
Ivermectin—Anaemia—Epirubicin—thyroid cancer	0.000234	0.00273	CcSEcCtD
Ivermectin—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00023	0.00365	CbGpPWpGaD
Ivermectin—Vertigo—Epirubicin—thyroid cancer	0.000228	0.00266	CcSEcCtD
Ivermectin—Leukopenia—Epirubicin—thyroid cancer	0.000227	0.00265	CcSEcCtD
Ivermectin—Back pain—Doxorubicin—thyroid cancer	0.000227	0.00265	CcSEcCtD
Ivermectin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000225	0.00356	CbGpPWpGaD
Ivermectin—Cough—Epirubicin—thyroid cancer	0.000221	0.00258	CcSEcCtD
Ivermectin—Convulsion—Epirubicin—thyroid cancer	0.000219	0.00256	CcSEcCtD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000218	0.00345	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—THRB—thyroid cancer	0.000217	0.00344	CbGpPWpGaD
Ivermectin—Anaemia—Doxorubicin—thyroid cancer	0.000217	0.00253	CcSEcCtD
Ivermectin—Chest pain—Epirubicin—thyroid cancer	0.000216	0.00252	CcSEcCtD
Ivermectin—Arthralgia—Epirubicin—thyroid cancer	0.000216	0.00252	CcSEcCtD
Ivermectin—Myalgia—Epirubicin—thyroid cancer	0.000216	0.00252	CcSEcCtD
Ivermectin—Discomfort—Epirubicin—thyroid cancer	0.000213	0.00249	CcSEcCtD
Ivermectin—Vertigo—Doxorubicin—thyroid cancer	0.000211	0.00246	CcSEcCtD
Ivermectin—Leukopenia—Doxorubicin—thyroid cancer	0.00021	0.00245	CcSEcCtD
Ivermectin—Confusional state—Epirubicin—thyroid cancer	0.000208	0.00243	CcSEcCtD
Ivermectin—Oedema—Epirubicin—thyroid cancer	0.000207	0.00241	CcSEcCtD
Ivermectin—Cough—Doxorubicin—thyroid cancer	0.000204	0.00239	CcSEcCtD
Ivermectin—ABCC2—NRF2 pathway—NRG1—thyroid cancer	0.000204	0.00323	CbGpPWpGaD
Ivermectin—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000203	0.00322	CbGpPWpGaD
Ivermectin—Convulsion—Doxorubicin—thyroid cancer	0.000203	0.00237	CcSEcCtD
Ivermectin—Tachycardia—Epirubicin—thyroid cancer	0.000202	0.00235	CcSEcCtD
Ivermectin—Hyperhidrosis—Epirubicin—thyroid cancer	0.0002	0.00233	CcSEcCtD
Ivermectin—Arthralgia—Doxorubicin—thyroid cancer	0.000199	0.00233	CcSEcCtD
Ivermectin—Myalgia—Doxorubicin—thyroid cancer	0.000199	0.00233	CcSEcCtD
Ivermectin—Chest pain—Doxorubicin—thyroid cancer	0.000199	0.00233	CcSEcCtD
Ivermectin—ABCG2—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000199	0.00316	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—HPGD—thyroid cancer	0.000198	0.00314	CbGpPWpGaD
Ivermectin—Discomfort—Doxorubicin—thyroid cancer	0.000197	0.0023	CcSEcCtD
Ivermectin—Anorexia—Epirubicin—thyroid cancer	0.000197	0.0023	CcSEcCtD
Ivermectin—Hypotension—Epirubicin—thyroid cancer	0.000193	0.00225	CcSEcCtD
Ivermectin—Confusional state—Doxorubicin—thyroid cancer	0.000193	0.00225	CcSEcCtD
Ivermectin—NR1H4—Generic Transcription Pathway—RXRA—thyroid cancer	0.000191	0.00303	CbGpPWpGaD
Ivermectin—Oedema—Doxorubicin—thyroid cancer	0.000191	0.00223	CcSEcCtD
Ivermectin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000188	0.0022	CcSEcCtD
Ivermectin—Tachycardia—Doxorubicin—thyroid cancer	0.000187	0.00218	CcSEcCtD
Ivermectin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000185	0.00216	CcSEcCtD
Ivermectin—Dyspnoea—Epirubicin—thyroid cancer	0.000184	0.00215	CcSEcCtD
Ivermectin—Somnolence—Epirubicin—thyroid cancer	0.000184	0.00214	CcSEcCtD
Ivermectin—Anorexia—Doxorubicin—thyroid cancer	0.000182	0.00213	CcSEcCtD
Ivermectin—NR1H4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000182	0.00288	CbGpPWpGaD
Ivermectin—Decreased appetite—Epirubicin—thyroid cancer	0.00018	0.0021	CcSEcCtD
Ivermectin—Hypotension—Doxorubicin—thyroid cancer	0.000179	0.00209	CcSEcCtD
Ivermectin—Fatigue—Epirubicin—thyroid cancer	0.000178	0.00208	CcSEcCtD
Ivermectin—Pain—Epirubicin—thyroid cancer	0.000177	0.00206	CcSEcCtD
Ivermectin—Constipation—Epirubicin—thyroid cancer	0.000177	0.00206	CcSEcCtD
Ivermectin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—thyroid cancer	0.000175	0.00278	CbGpPWpGaD
Ivermectin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000174	0.00203	CcSEcCtD
Ivermectin—Dyspnoea—Doxorubicin—thyroid cancer	0.00017	0.00199	CcSEcCtD
Ivermectin—Feeling abnormal—Epirubicin—thyroid cancer	0.00017	0.00199	CcSEcCtD
Ivermectin—Somnolence—Doxorubicin—thyroid cancer	0.00017	0.00198	CcSEcCtD
Ivermectin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000169	0.00197	CcSEcCtD
Ivermectin—Decreased appetite—Doxorubicin—thyroid cancer	0.000166	0.00194	CcSEcCtD
Ivermectin—Fatigue—Doxorubicin—thyroid cancer	0.000165	0.00192	CcSEcCtD
Ivermectin—Urticaria—Epirubicin—thyroid cancer	0.000164	0.00192	CcSEcCtD
Ivermectin—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000164	0.0026	CbGpPWpGaD
Ivermectin—Pain—Doxorubicin—thyroid cancer	0.000164	0.00191	CcSEcCtD
Ivermectin—Constipation—Doxorubicin—thyroid cancer	0.000164	0.00191	CcSEcCtD
Ivermectin—Abdominal pain—Epirubicin—thyroid cancer	0.000163	0.00191	CcSEcCtD
Ivermectin—Body temperature increased—Epirubicin—thyroid cancer	0.000163	0.00191	CcSEcCtD
Ivermectin—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000163	0.00258	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000161	0.00255	CbGpPWpGaD
Ivermectin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000158	0.00184	CcSEcCtD
Ivermectin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000156	0.00183	CcSEcCtD
Ivermectin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000156	0.00246	CbGpPWpGaD
Ivermectin—NR1H4—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000153	0.00242	CbGpPWpGaD
Ivermectin—ABCC1—Disease—TRIM24—thyroid cancer	0.000153	0.00242	CbGpPWpGaD
Ivermectin—Hypersensitivity—Epirubicin—thyroid cancer	0.000152	0.00178	CcSEcCtD
Ivermectin—Urticaria—Doxorubicin—thyroid cancer	0.000152	0.00177	CcSEcCtD
Ivermectin—Body temperature increased—Doxorubicin—thyroid cancer	0.000151	0.00176	CcSEcCtD
Ivermectin—Abdominal pain—Doxorubicin—thyroid cancer	0.000151	0.00176	CcSEcCtD
Ivermectin—ABCC1—Metabolism—MINPP1—thyroid cancer	0.00015	0.00238	CbGpPWpGaD
Ivermectin—Asthenia—Epirubicin—thyroid cancer	0.000148	0.00173	CcSEcCtD
Ivermectin—NR1H4—Gene Expression—TPR—thyroid cancer	0.000147	0.00232	CbGpPWpGaD
Ivermectin—Pruritus—Epirubicin—thyroid cancer	0.000146	0.00171	CcSEcCtD
Ivermectin—ABCC1—Disease—CHST14—thyroid cancer	0.000144	0.00227	CbGpPWpGaD
Ivermectin—Diarrhoea—Epirubicin—thyroid cancer	0.000141	0.00165	CcSEcCtD
Ivermectin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000141	0.00164	CcSEcCtD
Ivermectin—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000139	0.00221	CbGpPWpGaD
Ivermectin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000139	0.00219	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—MEN1—thyroid cancer	0.000138	0.00218	CbGpPWpGaD
Ivermectin—Asthenia—Doxorubicin—thyroid cancer	0.000137	0.0016	CcSEcCtD
Ivermectin—Dizziness—Epirubicin—thyroid cancer	0.000137	0.0016	CcSEcCtD
Ivermectin—ABCC1—Disease—TRIM33—thyroid cancer	0.000136	0.00215	CbGpPWpGaD
Ivermectin—Pruritus—Doxorubicin—thyroid cancer	0.000135	0.00158	CcSEcCtD
Ivermectin—ABCG2—Metabolism—MINPP1—thyroid cancer	0.000132	0.0021	CbGpPWpGaD
Ivermectin—Vomiting—Epirubicin—thyroid cancer	0.000131	0.00153	CcSEcCtD
Ivermectin—GABRB3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000131	0.00208	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000131	0.00208	CbGpPWpGaD
Ivermectin—Diarrhoea—Doxorubicin—thyroid cancer	0.000131	0.00153	CcSEcCtD
Ivermectin—Rash—Epirubicin—thyroid cancer	0.00013	0.00152	CcSEcCtD
Ivermectin—Dermatitis—Epirubicin—thyroid cancer	0.00013	0.00152	CcSEcCtD
Ivermectin—Headache—Epirubicin—thyroid cancer	0.000129	0.00151	CcSEcCtD
Ivermectin—GABRB3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000129	0.00205	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—NDUFA13—thyroid cancer	0.000128	0.00202	CbGpPWpGaD
Ivermectin—Dizziness—Doxorubicin—thyroid cancer	0.000126	0.00148	CcSEcCtD
Ivermectin—GABRB3—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000123	0.00195	CbGpPWpGaD
Ivermectin—Nausea—Epirubicin—thyroid cancer	0.000123	0.00143	CcSEcCtD
Ivermectin—Vomiting—Doxorubicin—thyroid cancer	0.000122	0.00142	CcSEcCtD
Ivermectin—NR1H4—Generic Transcription Pathway—PPARG—thyroid cancer	0.000121	0.00191	CbGpPWpGaD
Ivermectin—Rash—Doxorubicin—thyroid cancer	0.000121	0.00141	CcSEcCtD
Ivermectin—Dermatitis—Doxorubicin—thyroid cancer	0.00012	0.00141	CcSEcCtD
Ivermectin—ABCC2—Transmembrane transport of small molecules—CP—thyroid cancer	0.00012	0.0019	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00012	0.0019	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—CHST14—thyroid cancer	0.00012	0.0019	CbGpPWpGaD
Ivermectin—Headache—Doxorubicin—thyroid cancer	0.00012	0.0014	CcSEcCtD
Ivermectin—ABCC1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000119	0.00188	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000119	0.00188	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000118	0.00187	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000117	0.00185	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—TPR—thyroid cancer	0.000114	0.0018	CbGpPWpGaD
Ivermectin—Nausea—Doxorubicin—thyroid cancer	0.000114	0.00133	CcSEcCtD
Ivermectin—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000113	0.00179	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—NDUFA13—thyroid cancer	0.000113	0.00178	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—PRKAR1A—thyroid cancer	0.000112	0.00178	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—CHST14—thyroid cancer	0.000106	0.00168	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000105	0.00166	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000105	0.00166	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000103	0.00163	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000102	0.00161	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.83e-05	0.00156	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—HPGD—thyroid cancer	9.69e-05	0.00153	CbGpPWpGaD
Ivermectin—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	9.67e-05	0.00153	CbGpPWpGaD
Ivermectin—GABRB3—Neuronal System—BRAF—thyroid cancer	9.45e-05	0.0015	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—RXRA—thyroid cancer	9.22e-05	0.00146	CbGpPWpGaD
Ivermectin—ABCC1—Disease—TCF7L1—thyroid cancer	9.08e-05	0.00144	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9e-05	0.00143	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	8.95e-05	0.00142	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.9e-05	0.00141	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—SLC5A5—thyroid cancer	8.53e-05	0.00135	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—HPGD—thyroid cancer	8.53e-05	0.00135	CbGpPWpGaD
Ivermectin—GABRB3—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.26e-05	0.00131	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.99e-05	0.00127	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.86e-05	0.00124	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.83e-05	0.00124	CbGpPWpGaD
Ivermectin—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.56e-05	0.0012	CbGpPWpGaD
Ivermectin—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	7.54e-05	0.00119	CbGpPWpGaD
Ivermectin—ABCC1—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.47e-05	0.00118	CbGpPWpGaD
Ivermectin—GABRB3—BDNF signaling pathway—HRAS—thyroid cancer	7.37e-05	0.00117	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—RXRA—thyroid cancer	7.17e-05	0.00114	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—MINPP1—thyroid cancer	7.15e-05	0.00113	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.97e-05	0.0011	CbGpPWpGaD
Ivermectin—ABCC1—Disease—TPR—thyroid cancer	6.65e-05	0.00105	CbGpPWpGaD
Ivermectin—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.58e-05	0.00104	CbGpPWpGaD
Ivermectin—ABCC1—Disease—PRKAR1A—thyroid cancer	6.54e-05	0.00104	CbGpPWpGaD
Ivermectin—GABRB3—BDNF signaling pathway—AKT1—thyroid cancer	6.51e-05	0.00103	CbGpPWpGaD
Ivermectin—ABCC1—Disease—MEN1—thyroid cancer	6.25e-05	0.000989	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—NDUFA13—thyroid cancer	6.08e-05	0.000963	CbGpPWpGaD
Ivermectin—CYP3A4—Biological oxidations—RXRA—thyroid cancer	6e-05	0.00095	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—PPARG—thyroid cancer	5.82e-05	0.000922	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—CHST14—thyroid cancer	5.72e-05	0.000906	CbGpPWpGaD
Ivermectin—GABRB3—Transmission across Chemical Synapses—HRAS—thyroid cancer	5.67e-05	0.000898	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	5.65e-05	0.000895	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	5.65e-05	0.000895	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—TPR—thyroid cancer	5.57e-05	0.000881	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	5.56e-05	0.000881	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—PRKAR1A—thyroid cancer	5.48e-05	0.000867	CbGpPWpGaD
Ivermectin—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	5.23e-05	0.000828	CbGpPWpGaD
Ivermectin—ABCC1—Disease—CALCA—thyroid cancer	4.97e-05	0.000788	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.96e-05	0.000786	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—TPR—thyroid cancer	4.9e-05	0.000775	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—PRKAR1A—thyroid cancer	4.82e-05	0.000763	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—HPGD—thyroid cancer	4.61e-05	0.00073	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—PPARG—thyroid cancer	4.53e-05	0.000717	CbGpPWpGaD
Ivermectin—ABCC1—Disease—CDK1—thyroid cancer	4.5e-05	0.000713	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	4.45e-05	0.000704	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—MINPP1—thyroid cancer	4.41e-05	0.000698	CbGpPWpGaD
Ivermectin—GABRB3—Neuronal System—HRAS—thyroid cancer	4.34e-05	0.000688	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.23e-05	0.00067	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—SLC5A5—thyroid cancer	4.17e-05	0.00066	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	4.02e-05	0.000636	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.9e-05	0.000618	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	3.88e-05	0.000614	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.75e-05	0.000593	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—SLC5A5—thyroid cancer	3.67e-05	0.000581	CbGpPWpGaD
Ivermectin—ABCC1—Disease—NRG1—thyroid cancer	3.61e-05	0.000572	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—PTGS2—thyroid cancer	3.56e-05	0.000564	CbGpPWpGaD
Ivermectin—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.56e-05	0.000563	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—CHST14—thyroid cancer	3.52e-05	0.000558	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—RXRA—thyroid cancer	3.5e-05	0.000554	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.4e-05	0.000539	CbGpPWpGaD
Ivermectin—ABCC1—Disease—TERT—thyroid cancer	3.25e-05	0.000514	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—PTEN—thyroid cancer	3.1e-05	0.000492	CbGpPWpGaD
Ivermectin—ABCC1—Disease—HIF1A—thyroid cancer	3.1e-05	0.000491	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—RXRA—thyroid cancer	3.08e-05	0.000488	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.98e-05	0.000472	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—HPGD—thyroid cancer	2.84e-05	0.00045	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—TPR—thyroid cancer	2.65e-05	0.000419	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.65e-05	0.000419	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—PRKAR1A—thyroid cancer	2.6e-05	0.000412	CbGpPWpGaD
Ivermectin—ABCC1—Disease—BRAF—thyroid cancer	2.57e-05	0.000407	CbGpPWpGaD
Ivermectin—NR1H4—Gene Expression—AKT1—thyroid cancer	2.3e-05	0.000364	CbGpPWpGaD
Ivermectin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.24e-05	0.000354	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—PPARG—thyroid cancer	2.21e-05	0.00035	CbGpPWpGaD
Ivermectin—ABCC1—Disease—PTGS2—thyroid cancer	2.08e-05	0.000329	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.98e-05	0.000314	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—PPARG—thyroid cancer	1.94e-05	0.000308	CbGpPWpGaD
Ivermectin—ABCC1—Disease—PTEN—thyroid cancer	1.81e-05	0.000287	CbGpPWpGaD
Ivermectin—NR1H4—Metabolism—AKT1—thyroid cancer	1.79e-05	0.000283	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—PTGS2—thyroid cancer	1.74e-05	0.000275	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—RXRA—thyroid cancer	1.67e-05	0.000264	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—TPR—thyroid cancer	1.63e-05	0.000258	CbGpPWpGaD
Ivermectin—ABCC1—Disease—NRAS—thyroid cancer	1.62e-05	0.000256	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.6e-05	0.000254	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—PTGS2—thyroid cancer	1.53e-05	0.000242	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—PTEN—thyroid cancer	1.52e-05	0.00024	CbGpPWpGaD
Ivermectin—ABCC1—Disease—KRAS—thyroid cancer	1.39e-05	0.00022	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—PTEN—thyroid cancer	1.33e-05	0.000211	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.22e-05	0.000193	CbGpPWpGaD
Ivermectin—ABCC1—Disease—HRAS—thyroid cancer	1.18e-05	0.000187	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—PPARG—thyroid cancer	1.05e-05	0.000166	CbGpPWpGaD
Ivermectin—ABCC1—Disease—AKT1—thyroid cancer	1.04e-05	0.000165	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—RXRA—thyroid cancer	1.03e-05	0.000162	CbGpPWpGaD
Ivermectin—ABCC1—Metabolism—AKT1—thyroid cancer	8.74e-06	0.000138	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—PTGS2—thyroid cancer	8.27e-06	0.000131	CbGpPWpGaD
Ivermectin—ABCG2—Metabolism—AKT1—thyroid cancer	7.69e-06	0.000122	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—PTEN—thyroid cancer	7.21e-06	0.000114	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—PPARG—thyroid cancer	6.48e-06	0.000103	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.1e-06	8.07e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—PTEN—thyroid cancer	4.44e-06	7.04e-05	CbGpPWpGaD
Ivermectin—ABCB1—Metabolism—AKT1—thyroid cancer	4.16e-06	6.58e-05	CbGpPWpGaD
Ivermectin—CYP3A4—Metabolism—AKT1—thyroid cancer	2.56e-06	4.06e-05	CbGpPWpGaD
